Ether a go-go potassium channels as human cervical cancer markers

Luz María Barajas Farias1, Deysi Bermúdez Ocaña, Lorenza Díaz

  • 1Pharmacology Section, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, México City, México.

Cancer Research
|October 7, 2004
PubMed

Insights

Ether a go-go (EAG) potassium channels are linked to cancer. Researchers found EAG expression and activity in cervical cancer, suggesting its potential as a diagnostic marker and therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Channel Physiology

Background:

  • Ether a go-go (EAG) potassium channels exhibit oncogenic properties.
  • EAG mRNA is typically found in the brain but is also present in some cancer cell lines.
  • Previous studies suggest antisense inhibition of EAG reduces cancer cell proliferation.

Purpose of the Study:

  • To investigate EAG mRNA expression and channel activity in human cervical cancer tissues.
  • To evaluate the potential of EAG as a tumor marker and therapeutic target for cervical cancer.

Main Methods:

  • Reverse transcription-PCR and Southern-blot for EAG mRNA detection.
  • Immunochemistry to identify EAG protein expression.
  • Patch-clamp recordings to analyze EAG-mediated currents in cervical cancer cells.

Main Results:

  • EAG mRNA was detected in 100% of cancerous cervical samples versus 33% of normal samples.
  • EAG protein was present in cervical cancer cells.
  • EAG channel activity was confirmed in human cervical tumors, showing typical modulated currents.

Conclusions:

  • EAG expression and activity are significantly elevated in human cervical cancer.
  • EAG represents a potential tumor marker for cervical cancer diagnosis.
  • EAG channels are a potential therapeutic target for cervical cancer treatment.

Related Concept Videos

Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: